Sheeba Thomas, Elisabet Manasanch, Sundar Jagannath, Neha Korde, Hans Lee, David Berrios, Krina Patel, Swami Iyer, Sham Mailankody, Behrang Amini, Pei Lin, Zuzana Berkova, Donna Weber, Gregory Kaufman, Lei Feng, Michelle Hildebrandt, Linghua Wang, Sattva Neelapu, Robert Orlowski, Ola Landgren. "Final results of a multi-center phase 2 trial of isatuximab-lenalidomide in patients with high risk smoldering multiple myeloma (HRSMM)." Blood, 2025. doi:10.1182/blood-2025-5834